- Home
- GME vs QGEN Comparison
GME vs QGEN Comparison
Compare GME & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GME | QGEN |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Electronics Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 10.2B |
| IPO Year | 2002 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GME | QGEN |
|---|---|---|
| Price | $23.54 | $50.49 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $13.50 | ★ $51.30 |
| AVG Volume (30 Days) | ★ 11.2M | 3.6M |
| Earning Date | 03-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | 387.37 | ★ 409.76 |
| EPS | 0.83 | ★ 2.04 |
| Revenue | ★ $3,808,200,000.00 | $2,089,999,000.00 |
| Revenue This Year | $9.86 | $7.75 |
| Revenue Next Year | $2.83 | $6.13 |
| P/E Ratio | $28.43 | ★ $24.90 |
| Revenue Growth | N/A | ★ 5.65 |
| 52 Week Low | $19.93 | $39.61 |
| 52 Week High | $35.81 | $57.82 |
Technical Indicators
Market Signals| Indicator | GME | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.14 | 57.39 |
| Support Level | $23.36 | $50.71 |
| Resistance Level | $25.21 | $51.71 |
| Average True Range (ATR) | 1.01 | 1.19 |
| MACD | -0.10 | -0.39 |
| Stochastic Oscillator | 34.06 | 48.35 |
Price Performance
Historical ComparisonAbout GME GameStop Corporation
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).